MDxHealth SA

DB:A3E19Y Stock Report

Market Cap: €85.5m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

MDxHealth Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Mike McGarrity

Chief executive officer

US$571.1k

Total compensation

CEO salary percentage78.8%
CEO tenure4.8yrs
CEO ownershipn/a
Management average tenure4.7yrs
Board average tenure6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Mike McGarrity's remuneration changed compared to MDxHealth's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2023n/an/a

-US$45m

Jun 30 2023n/an/a

-US$48m

Mar 31 2023n/an/a

-US$47m

Dec 31 2022US$571kUS$450k

-US$44m

Sep 30 2022n/an/a

-US$40m

Jun 30 2022n/an/a

-US$34m

Mar 31 2022n/an/a

-US$31m

Dec 31 2021US$540kUS$386k

-US$29m

Sep 30 2021n/an/a

-US$28m

Jun 30 2021n/an/a

-US$28m

Mar 31 2021n/an/a

-US$28m

Dec 31 2020US$582kUS$452k

-US$29m

Sep 30 2020n/an/a

-US$36m

Jun 30 2020n/an/a

-US$43m

Mar 31 2020n/an/a

-US$43m

Dec 31 2019US$442kUS$347k

-US$43m

Compensation vs Market: Mike's total compensation ($USD571.15K) is above average for companies of similar size in the German market ($USD425.92K).

Compensation vs Earnings: Mike's compensation has increased whilst the company is unprofitable.

CEO

Mike McGarrity (60 yo)

4.8yrs

Tenure

US$571,149

Compensation

Mr. Michael K. McGarrity, also known as Mike, has been the Chief Executive Officer and Executive Director at MDxHealth SA since February 18, 2019. Mr. McGarrity has experience in the healthcare industry wi...

Leadership Team

NamePositionTenureCompensationOwnership
Michael McGarrity
CEO & Executive Director4.8yrsUS$571.15kno data
Ron Kalfus
Chief Financial Officer4.4yrsno data0%
€ 0
Joseph Sollee
Executive VP of Corporate Development & General Counselno datano data0%
€ 0
John Bellano
Chief Commercial Officer4.5yrsno data0%
€ 0
Miriam Reyes
Executive Vice President of Operations4.9yrsno datano data
Wim Van Criekinge
Chief Scientific Officerno datano datano data

4.7yrs

Average Tenure

52.5yo

Average Age

Experienced Management: A3E19Y's management team is considered experienced (4.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Michael McGarrity
CEO & Executive Director4.8yrsUS$571.15kno data
Donnie Hardison
Independent Non-Executive Director2.3yrsUS$76.03kno data
Hilde Windels
Independent Non-Executive Director6.2yrsUS$49.26k0%
€ 0
Jan Pensaert
Non-Executive Director9.6yrsUS$10.71k0%
€ 0
Jan Groen
Advisor to the Board4.8yrsUS$798.45kno data
James Herman
Member of Scientific Advisory Boardno datano datano data
Gerrit Meijer
Member of Scientific Advisory Boardno datano datano data
Jonathan Epstein
Member of Scientific Advisory Board12.8yrsno datano data
Eric Wallen
Member of Scientific Advisory Board12.8yrsno datano data
Regine Slagmulder
Independent Non-Executive Director3.3yrsUS$63.18k0.22%
€ 185.0k
Koen Hoffman
Independent Non-Executive Chairman5.9yrsUS$109.22k0%
€ 0
Godelieve Verplancke
Independent Non-Executive Director6.3yrsUS$55.68k0%
€ 0

6.0yrs

Average Tenure

59yo

Average Age

Experienced Board: A3E19Y's board of directors are considered experienced (6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/12/20 11:04
End of Day Share Price 2023/12/15 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MDxHealth SA is covered by 13 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael Ruzic-GauthierBerenberg
Mark MassaroBTIG
Roderick VerhelstDegroof Petercam